To provide for a limitation on availability of funds for Related Agency and Food and Drug Administration, Buildings and Facilities for fiscal year 2024.

HR 2296 sets a spending limit of $11,788,000 for building and facility projects at the Food and Drug Administration (FDA) and an unspecified "Related Agency" during fiscal year 2024. This bill directly restricts the budget available for infrastructure improvements at these two entities, capping all allocated funds for this purpose. The provision applies to all existing and future funding designated for these specific projects in the 2024 budget cycle. It does not alter FDA operations or regulations, only the financial allocation for physical facilities.